Interdisciplinary Approach to Identification and Validation of Novel Therapeutic Targets for Alzheimer's Disease (R01)

Archived

National Institutes of Health

View on Grants.gov 📝 Build a proposal template ★ Save

Description

This funding opportunity supports integrative, interdisciplinary research focused on the identification and preclinical validation of novel therapeutic targets within molecular networks involved in different stages of Alzheimers disease (AD) pathogenesis. The use of the multiple Program Director/Principal Investigator (PD/PI) option aims to maximize the potential of team science efforts necessary to achieve the programmatic goals of this funding opportunity.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster <br/>FBOWebmaster@OD.NIH.GOV <br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedOct 15, 2012
  • ClosesJan 14, 2013
  • Award ceiling$1,000,000
  • Program funding$23,000,000
  • CFDA93.866
Categories
Health

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro